These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 19270210)

  • 1. Monitoring cardiovascular risk factors in children on dialysis.
    Shroff R
    Perit Dial Int; 2009 Feb; 29 Suppl 2():S173-5. PubMed ID: 19270210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mineral metabolism and cardiovascular morbidity and mortality risk: peritoneal dialysis patients compared with haemodialysis patients.
    Noordzij M; Korevaar JC; Bos WJ; Boeschoten EW; Dekker FW; Bossuyt PM; Krediet RT
    Nephrol Dial Transplant; 2006 Sep; 21(9):2513-20. PubMed ID: 16799173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular disease in children with chronic kidney disease.
    Mitsnefes MM
    J Am Soc Nephrol; 2012 Apr; 23(4):578-85. PubMed ID: 22383696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular risk factors in children on dialysis: an update.
    Querfeld U; Schaefer F
    Pediatr Nephrol; 2020 Jan; 35(1):41-57. PubMed ID: 30382333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uraemic vasculopathy in children with chronic kidney disease: prevention or damage limitation?
    Shroff R; Quinlan C; Mitsnefes M
    Pediatr Nephrol; 2011 Jun; 26(6):853-65. PubMed ID: 21080003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Septicemia, access, cardiovascular disease, and death in dialysis patients.
    O'Seaghdha CM; Foley RN
    Perit Dial Int; 2005; 25(6):534-40. PubMed ID: 16411515
    [No Abstract]   [Full Text] [Related]  

  • 7. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients.
    K/DOQI Workgroup
    Am J Kidney Dis; 2005 Apr; 45(4 Suppl 3):S1-153. PubMed ID: 15806502
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical epidemiology of cardiovascular disease in chronic kidney disease prior to dialysis.
    Levin A
    Semin Dial; 2003; 16(2):101-5. PubMed ID: 12641872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sympathetic overactivity--the Cinderella of cardiovascular risk factors in dialysis patients.
    Vonend O; Rump LC; Ritz E
    Semin Dial; 2008; 21(4):326-30. PubMed ID: 18627567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular impact in patients undergoing maintenance hemodialysis: Clinical management considerations.
    Chirakarnjanakorn S; Navaneethan SD; Francis GS; Tang WH
    Int J Cardiol; 2017 Apr; 232():12-23. PubMed ID: 28108129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inadequate treatment of cardiovascular disease and cardiovascular disease risk factors in dialysis patients: a commentary.
    Culleton BF; Hemmelgarn B
    Semin Dial; 2004; 17(5):342-5. PubMed ID: 15461738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of vascular calcification inhibitors in preventing vascular dysfunction and mortality in hemodialysis patients.
    Gungor O; Kocyigit I; Yilmaz MI; Sezer S
    Semin Dial; 2018 Jan; 31(1):72-81. PubMed ID: 28608927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular disease and bridging the diagnostic gap.
    Wachira JK; Stys TP
    S D Med; 2013 Sep; 66(9):366-9. PubMed ID: 24279112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Focus on: physical exercise in hemodialysis patients.
    Tentori F
    J Nephrol; 2008; 21(6):808-12. PubMed ID: 19034864
    [No Abstract]   [Full Text] [Related]  

  • 15. Evolution of Cardiovascular Disease During the Transition to End-Stage Renal Disease.
    Bansal N
    Semin Nephrol; 2017 Mar; 37(2):120-131. PubMed ID: 28410646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Epidemiology of cardiovascular disease in CKD-MBD].
    Di Micco L; Mozzillo GR; Cianciaruso B
    G Ital Nefrol; 2009; 26 Suppl 49():S3-10. PubMed ID: 19941272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Therapeutic Options for the Treatment of Mineral Metabolism Abnormalities in End Stage Renal Disease.
    Kendrick J; Chonchol M
    Semin Dial; 2015; 28(6):610-9. PubMed ID: 26278462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular biomarkers in chronic kidney disease.
    Park SH; Stenvinkel P; Lindholm B
    J Ren Nutr; 2012 Jan; 22(1):120-7. PubMed ID: 22200428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are the high mortality rates in dialysis patients mainly due to cardiovascular causes?
    Krediet RT; Boeschoten EW; Dekker FW
    Nephrol Dial Transplant; 2012 Feb; 27(2):481-3. PubMed ID: 21984555
    [No Abstract]   [Full Text] [Related]  

  • 20. Reducing the burden of cardiovascular disease in children with chronic kidney disease: prevention vs. damage limitation.
    Shroff R
    Pediatr Nephrol; 2021 Aug; 36(8):2537-2544. PubMed ID: 34143301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.